Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024602) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis' on June 02.

Brief Summary: This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, food effect of ASC50 tablets in healthy adult participants and adult participants with mild to moderate plaque psoriasis.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Plaque Psoriasis

Intervention: DRUG: ASC50 tablets or matching p...